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The Role of  NF-kB p65 in Subarachnoid 
Hemorrhage Induced Secondary Brain Injury
Molly Lawrence
Mentor: Itender Singh
Subarachnoid hemorrhage (SAH), primarily caused by rupture of a cerebral aneurysm, 
refers to the extravasation of blood into subarachnoid space between the pial and 
arachnoid membranes. With high mortality and morbidity rates, the initial hemorrhage 
itself is often fatal, but the primary cause of poor outcomes is through the secondary 
brain injuries that develop in the days following SAH. There are two separate categories 
of these damages, distinguished as early brain injury (EBI) and delayed cerebral ischemia 
(DCI). Occurring 1-3 days following SAH, EBI presents as neuroinflammation, cerebral 
edema, and blood-brain barrier (BBB) disruption. DCI, the more common and 
devastating category, describes the slower onset damages, 4-12 days post-SAH, including 
microcirculatory deficits and large artery vasospasm. There is strong evidence that 
vascular deficits are the main cause of these secondary brain injuries, with blood-brain 
barrier (BBB) disruption leading to EBI and large artery vasopasm leading to DCI. Several 
previous studies have shown that a strong genetic risk factor for these poor outcomes 
after SAH is the presence of apolipoprotein E4 allele. The APOE4 linked pathway 
involves cyclophilin A (CypA), a cell signaling molecule that causes inflammation 
through activation of transcription factor nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-kB) p65 and resulting induction of matrix metalloproteinase-9 
(MMP9) and BBB disruption. However, the role of CypA in secondary brain injury has 
not yet been clearly established. Early findings showing high levels of CypA in rodents 
after SAH, we hypothesize that the CypA- NF-kB p65 -MMP9 pathway plays a critical 
role in SAH-induced EBI and DCI.
With CypA inhibition and MMP9 knockouts displaying reduced post-SAH BBB 
leakage and vascular deficits, our objective for this study was to confirm the role of 
NF-kB p65 in this pathway. To assess this, wild-type C57BL6 mice were administered 
a pharmacological inhibitor of NF-kb p65, ammonium pyrrolidinedithiocarbamate 
(PDTC), via intraperitoneal injection the day of SAH surgery and daily for three 
days following (Day 0 - Day 3). Cognitive and motor skills of the mice were assessed 
Day 0 - Day 3 via neuroscoring and rotarod along with their littermate controls (also 
administered SAH). On Day 3, the mice were sacrificed by India ink-gelatin perfusion, 
which fixes and stains the brain vessels to allow imaging and measurement of the middle 
cerebral artery to assess vasospasm. The mice with p65 inhibition showed significantly 
less cognitive impairment and vasospasm than their littermate controls, corroborating 
our hypothesis of the role of the transcription factor in the induction of post-SAH 
deficits and suggesting p65 to be a promising potential therapeutic target for SAH.
